RemedLtd (A302550) Stock Overview
Engages in the manufactures and supplies of medical devices worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
A302550 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Remed Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,175.00 |
| 52 Week High | ₩4,595.00 |
| 52 Week Low | ₩2,980.00 |
| Beta | 0.74 |
| 1 Month Change | -6.07% |
| 3 Month Change | -4.08% |
| 1 Year Change | -18.49% |
| 3 Year Change | 29.07% |
| 5 Year Change | -45.35% |
| Change since IPO | 1.44% |
Recent News & Updates
RemedLtd (KOSDAQ:302550) Seems To Use Debt Quite Sensibly
Sep 18
RemedLtd's (KOSDAQ:302550) Promising Earnings May Rest On Soft Foundations
Mar 25Recent updates
RemedLtd (KOSDAQ:302550) Seems To Use Debt Quite Sensibly
Sep 18RemedLtd's (KOSDAQ:302550) Promising Earnings May Rest On Soft Foundations
Mar 25Here's What's Concerning About RemedLtd's (KOSDAQ:302550) Returns On Capital
Dec 16Remed Co.,Ltd.'s (KOSDAQ:302550) 43% Price Boost Is Out Of Tune With Revenues
Nov 06RemedLtd's (KOSDAQ:302550) Profits Appear To Have Quality Issues
Aug 20Would RemedLtd (KOSDAQ:302550) Be Better Off With Less Debt?
Aug 12Investor Optimism Abounds Remed Co.,Ltd. (KOSDAQ:302550) But Growth Is Lacking
Jun 17Shareholder Returns
| A302550 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -5.6% | -3.3% | -5.1% |
| 1Y | -18.5% | -6.0% | 54.5% |
Return vs Industry: A302550 underperformed the KR Medical Equipment industry which returned -6% over the past year.
Return vs Market: A302550 underperformed the KR Market which returned 54.5% over the past year.
Price Volatility
| A302550 volatility | |
|---|---|
| A302550 Average Weekly Movement | 5.3% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 10.8% |
| 10% least volatile stocks in KR Market | 2.5% |
Stable Share Price: A302550 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A302550's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 89 | Geun-Yong Lee | remed.kr |
Remed Co.,Ltd. engages in the manufactures and supplies of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as tinnitus, insomnia, dementia, stress, anxiety, etc. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles.
Remed Co.,Ltd. Fundamentals Summary
| A302550 fundamental statistics | |
|---|---|
| Market cap | ₩99.85b |
| Earnings (TTM) | ₩6.48b |
| Revenue (TTM) | ₩24.48b |
Is A302550 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A302550 income statement (TTM) | |
|---|---|
| Revenue | ₩24.48b |
| Cost of Revenue | ₩10.36b |
| Gross Profit | ₩14.12b |
| Other Expenses | ₩7.65b |
| Earnings | ₩6.48b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 208.22 |
| Gross Margin | 57.69% |
| Net Profit Margin | 26.46% |
| Debt/Equity Ratio | 9.3% |
How did A302550 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/20 18:57 |
| End of Day Share Price | 2025/11/20 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Remed Co.,Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wan Ku | NH Investment & Securities Co., Ltd. |
| Kwan Jun Ra | NH Investment & Securities Co., Ltd. |
| Changmin Yoon | Shinhan Investment Corp. |